Monthly Archives: October 2011

H3 Biomedicine introduces cancer research and development operations in Cambridge

H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients’ cancers can reveal drug … Continue reading

Posted in Uncategorized | Leave a comment

NHS reforms & proposed spending questioned

According to John Appleby, Chief Economist at the King??™s Fund, deaths from heart attacks and cancer in the UK are falling despite lower spending on health than in countries such as France. This, he said calls attention to the Government??™s … Continue reading

Posted in Uncategorized | Leave a comment

Major changes at Journal of Vascular and Interventional Radiology

The Journal of Vascular and Interventional Radiology-the monthly, peer-reviewed flagship publication of the Society of Interventional Radiology-announced several major changes for 2011-all directed at highlighting the global impact of this minimally invasive medical specialty and its lead journal. Haskal notes … Continue reading

Posted in Uncategorized | Leave a comment

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

Zebrafish are the new fruit flies. Haskal notes that one of the journal’s new initiatives is to expand the ways in which it provides information by including new article types. "With James B. Spies, M.D., MPH, FSIR, professor and chair … Continue reading

Posted in Uncategorized | Leave a comment

GE to establish Global Pathology Imaging Centre of Excellence in Ontario

GE announced an agreement to establish its first Global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE and its digital pathology joint venture, Omnyx?„?, will invest $7.75M along with a $2.25M grant from the Health Technology Commercialization Program created … Continue reading

Posted in Uncategorized | Leave a comment

Lilly fourth quarter worldwide total revenue increases 4% to $6.187 billion

Eli Lilly and Company today announced financial results for the fourth quarter and full year of 2010. For the full year of 2010, worldwide Cialis sales increased 9 percent to $1.699 billion. U.S. Cialis sales for 2010 were $658.1 million, … Continue reading

Posted in Uncategorized | Leave a comment

DMP1 protein prevents endothelial cells to respond to VEGF

A team from the Metastasis Research Laboratory (GIGA-Cancer/Li??ge University Hospital) has just published, in the prestigious journal BLOOD, their work demonstrating that the DMP1 protein has previously unsuspected anti-angiogenic activities which could be used for the development of new treatments … Continue reading

Posted in Uncategorized | Leave a comment